Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab-hncq) for routine prophylaxis aimed at preventing or reducing bleeding episodes in patients aged 12 and older …
FDA Approves Hympavzi for Hemophilia Treatment, Offering Novel Approach to Bleeding Disorder Management Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test. This innovative test marks a significant advancement …
FDA Authorizes Groundbreaking Healgen Rapid Check COVID-19/Flu A&B Antigen Test Read More
WEST CHESTER, PA — Pocopson Home, a cornerstone of long-term healthcare in Chester County, has achieved national acclaim by being ranked among America’s Best Nursing Homes for 2025. This recognition, …
Pocopson Home Shines: Celebrated Among America’s Best Nursing Homes 2025, Elevating Community Pride Read More
BERWYN, PA — Panavance Therapeutics Inc. announced interim results from its Phase 1 clinical trial at the 2024 Visceral Medicine Congress in Leipzig, Germany. The study evaluates the safety and efficacy …
Panavance Unveils Game-Changing Data: A New Hope for Pancreatic Cancer Patients? Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced a pivotal development as the FDA lifted the clinical hold on its investigational drug application for OCU200.
FDA Greenlights Ocugen’s Revolutionary Eye Treatment: What It Means for Vision Care Read More
HARRISBURG, PA — In a strategic move aimed at enhancing access to critical mental health and substance use disorder services, the Pennsylvania Department of Human Services (DHS) has revealed plans …
Pennsylvania DHS Announces Rate Increase to Bolster Behavioral Health Services for Medicaid Recipients Read More
WASHINGTON, D.C. — In a bold leap forward in the fight against antimicrobial resistance (AMR), the U.S. Department of Health and Human Services (HHS), through the Advanced Research Projects Agency for …
HHS Launches TARGET Initiative to Combat Antibiotic Resistance with AI Innovation Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has made strides in the fight against neurodegenerative diseases with the filing of three new patents. These cover novel combination therapies involving their …
Annovis Bio Files Patents for Innovative Therapies in Neurodegenerative Disease Treatment Read More
WASHINGTON, D.C. — In a decisive move to bolster the global fight against the mpox outbreak, the U.S. Department of Health and Human Services (HHS), through its Administration for Strategic Preparedness …
HHS Boosts Global Mpox Vaccine Supply Amid Ongoing Public Health Threat Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. This innovative medication marks a significant …
FDA Approves Cobenfy, Pioneering New Approach to Schizophrenia Treatment Read More